Market Exclusive

Analyst Activity – Jefferies Group Raises Its Price Target On Atara Biotherapeutics (NASDAQ:ATRA) to

Analyst Ratings For Atara Biotherapeutics (NASDAQ:ATRA)

Today, Jefferies Group raised its price target on Atara Biotherapeutics (NASDAQ:ATRA) to per share.

Some recent analyst ratings include

Recent Insider Trading Activity For Atara Biotherapeutics (NASDAQ:ATRA)
Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 16.20% and institutional ownership of 75.92%.

Recent Trading Activity for Atara Biotherapeutics (NASDAQ:ATRA)
Shares of Atara Biotherapeutics closed the previous trading session at with 39.400001525878906 shares trading hands.

Exit mobile version